Dicerna Doses First Primary Hyperoxaluria Patient with DCR-PHXC in Group B Portion of PHYOX Phase 1 Clinical Trial, FDA Grants Orphan Drug Designation for DCR-PHXC for the Treatment of Primary Hyperoxaluria